Subashini Srinivasan1, Bruce L Daniel1, and Brian A Hargreaves1
1Radiology, Stanford University, Stanford, CA, United States
Synopsis
Pharmacokinetic (PK) models have been used to
estimate physiological parameters such as permeability and dispersion of the
contrast agent and is estimated using the acquired signal, pre-contrast T10,
and the acquisition flip angle. In this work, we have determined the dependence
of the dispersion models’ and
Tofts models’ PK
parameters on T10 and B1 maps, as well as the errors introduced by using
constant T10 and B1 values in 11 biopsy-proven tumors. Our
results show that PK parameters such as kep of Tofts model and kappa
of mLDRW dispersion model are less dependent on T10 and B1
and could potentially be used with higher accuracy and precision even when T10
and B1 maps are not acquired.Introduction
Pharmacokinetic (PK) models have been used to
estimate physiological parameters such as permeability [1] and
dispersion [2] of the contrast agent from the temporal changes
in gadolinium concentration. The contrast agent concentration can be estimated using
the RF-spoiled gradient echo signal, pre-contrast T
10, and the
acquisition flip angle. However, many datasets are acquired without T
10
and B
1 map due to longer acquisition duration. Several simulation
studies [3] have shown significant errors in K
trans and v
e
values of Tofts model due to their dependence on T
10 and B
1,
assuming that the model perfectly describes the acquired data. The purpose of
this study is to determine the dependence of the dispersion models’ [2] and Tofts models’ PK parameters on T
10 and B
1
values, as well as the errors introduced by using constant T
10 and B
1
values using acquired patient data.
Methods
Figure 1 shows the variation in
concentration-time curves introduced by different choice of T10 and
B1 for the same signal-time curve. The effect of errors in T10
and B1 values on the PK parameters was studied in 6 patients with 11
biopsy-proven tumors (7 malignant, 6 in the right breast). 3D RF-spoiled
gradient echo fat-water separated DCE images were acquired using DISCO [4], a
pseudorandom ky-kz sampling scheme enabling a favorable
tradeoff between temporal and spatial resolution, on a 3T scanner (GE
Healthcare, Waukesha, WI). One
pre-contrast and four post-contrast images were acquired with high spatial
resolution of 0.5×0.6×1.0 mm and low temporal resolution of 2 min. Fourteen
images were acquired during the wash-in period with high temporal resolution of
13s and lower spatial resolution of 0.5×1.2×2.0 mm. Prior to the acquisition of
pre-contrast DCE images (FA=12°), 3D variable flip
angle (FA=2°, 5° and 8°) images with identical imaging parameters were acquired
to estimate the water-only T10 map [5]. A 2D multi-slice Bloch-Siegart B1
map [6] was also acquired with a low spatial resolution of 5×5×5 mm and was also used for correcting the T10
map. The DCE images, T10 and B1
maps were subsequently reconstructed to identical spatial resolution of 0.5×1.2×2.0 mm.
Voxel-by-voxel PK mapping was
performed using a standard Tofts model [1] with modified Fritz-Hansen arterial
input function as well as modified local density random walk (mLDRW) Dispersion
model [2]. The PK parameters were estimated for 11 tumors using the following
combinations of T10 and B1: (1) T10 map, B1
map, (2) T10 map, FA=[0.6 to 1.4]×12°, (3) B1 map, T10=[1000
to 2000] ms, (4) T10=1500ms, FA=[0.6 to 1.4]×12°, and (5) FA=12°, T10=[1000
to 2000] ms. The PK parameters estimated over the tumor ROI using the T10
and B1 maps was considered as the standard. Every other PK parameter
value was compared to the standard using the concordance correlation coefficient (ρc).
Results
The median of the B
1-corrected T
10
within the tumor ROI varied between 1116 ms and 1821 ms and the median relative
FA varied between 0.7 and 1.3. Figure 2 shows the box plot of ρ
c for different combinations of T
10
and B
1 values. Both kep of Tofts model and kappa of mLDRW
dispersion model have a higher ρc and
lower relative variation. The median and the range of ρ
c for each of the PK parameters for few
combinations of T
10 and B
1 are tabulated in Figure 3.
Parameters such as beta and mu have a lower ρc as
well as huge variation indicating their sensitivity to T
10 and B
1
map. These results show that it may be possible to create PK parameter maps
without acquiring T
10 and B
1 maps and using an average
value instead. However only few parameters such as k
ep and kappa
will have relatively high accuracy and precision, and parameters such as beta
will have lower precision.
Discussion
The data analysis assumed that the acquired T
10
and B
1 maps were accurate and the ρ
c
was calculated with the maps derived PK values as the standard. However, both T
1
and B
1 mapping introduces errors. The results also show that ρ
c is high when the average value of T
1
and B
1 maps are used and this, or the use of low-pass-filtered maps,
may reduce error propagation.
Conclusion
Pharmacokinetic parameters such as k
ep
of Tofts model and kappa of mLDRW dispersion model are less dependent on T
10
and B
1 and hence these PK maps could potentially be used clinically
with higher accuracy and precision even when T
10 and B
1
maps are not acquired.
Acknowledgements
Research support from NIH R01 EB009055 and
GE HealthcareReferences
[1] Tofts P, et al., JMRI 1999;10:223-232
[2] Mischi M, et al., IEEE EMBS, 2013
[3] Giovanni PD, et al., Phy. Med. Biol.
2010;55:121-132
[4] Saranathan M, et al., JMRI 2014;40(6):1392-1399
[5] Deoni SC, et al., MRM 2003; 49(3):515-526
[6] Sacolick L, et al., MRM 2010;
63(5):1315-1322